Tyra Biosciences

IPO

Next-Generation Precision Medicines

healthtech

biotech

Headquarters: Carlsbad, California
Employees: 11–50
Founded: 2019
Business Model: B2B
Website: tyra.bio

Total Funding: $156.0M
Valuation: $348.4MMar 2021
Last Round: $106.0M Series BMar 2021
Rounds: 2
Type: Public

About

Tyra Biosciences is a clinical-stage biotechnology company developing next-generation precision medicines targeting FGFR biology and acquired resistance in oncology. Its proprietary SNÅP discovery platform enables rapid structural snapshots of drug-target interactions, accelerating structure-based drug design from weeks to days. The company has raised over $156M in financing to advance its oncology pipeline.

Tech & App Stack

Tech & App Stack is available on paid plans

Upgrade to Silver or higher to reveal the full technology and app stack for any company.

View pricing

Sign up to view funding chart

Create a free account to see funding visualizations and detailed round data.

Create Free Account

Funding History

Secondary MarketSecondary MarketJan 2024

Jan 2024

Tyra Biosciences

About

Tech & App Stack

Sign up to view funding chart

Funding History

Investors

Sign up to view investors

Similar Companies